Hims & Hers Health (NYSE:HIMS) Shares Up 3.6% – Still a Buy?

Shares of Hims & Hers Health, Inc. (NYSE:HIMS) traded up 3.6% during mid-day trading on Thursday . The company traded as high as $29.47 and last traded at $29.16. 1,420,068 shares were traded during trading, a decline of 86% from the average session volume of 10,024,792 shares. The stock had previously closed at $28.15.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on HIMS shares. Canaccord Genuity Group raised their price objective on shares of Hims & Hers Health from $28.00 to $38.00 and gave the stock a “buy” rating in a research note on Monday, December 2nd. Piper Sandler reaffirmed a “neutral” rating and set a $21.00 target price (up previously from $18.00) on shares of Hims & Hers Health in a research note on Tuesday, November 5th. Bank of America downgraded shares of Hims & Hers Health from a “buy” rating to an “underperform” rating and decreased their price objective for the stock from $32.00 to $18.00 in a report on Thursday, November 14th. TD Cowen reissued a “buy” rating and set a $28.00 price target on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Finally, Morgan Stanley started coverage on Hims & Hers Health in a research note on Tuesday, December 17th. They set an “overweight” rating and a $42.00 target price for the company. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $22.80.

Hims & Hers Health Trading Up 4.0 %

The company has a market cap of $6.40 billion, a P/E ratio of 66.57 and a beta of 1.25. The stock’s 50-day moving average price is $26.15 and its 200-day moving average price is $21.41.

Hims & Hers Health (NYSE:HIMS) last released its earnings results on Monday, November 4th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.26. The company had revenue of $401.56 million for the quarter, compared to analysts’ expectations of $382.20 million. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The business’s revenue for the quarter was up 77.1% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.04) EPS. On average, research analysts anticipate that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Insider Buying and Selling at Hims & Hers Health

In other Hims & Hers Health news, CFO Oluyemi Okupe sold 9,868 shares of the business’s stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $19.96, for a total value of $196,965.28. Following the transaction, the chief financial officer now owns 195,988 shares in the company, valued at approximately $3,911,920.48. The trade was a 4.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Melissa Baird sold 58,750 shares of Hims & Hers Health stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $19.57, for a total value of $1,149,737.50. Following the sale, the chief operating officer now owns 630,166 shares in the company, valued at $12,332,348.62. This represents a 8.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,111,616 shares of company stock worth $27,448,767 over the last three months. 17.71% of the stock is owned by insiders.

Institutional Investors Weigh In On Hims & Hers Health

Hedge funds have recently added to or reduced their stakes in the stock. Quest Partners LLC increased its stake in shares of Hims & Hers Health by 22.6% in the third quarter. Quest Partners LLC now owns 4,373 shares of the company’s stock worth $81,000 after purchasing an additional 807 shares in the last quarter. CWM LLC increased its stake in Hims & Hers Health by 21.4% in the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock worth $110,000 after buying an additional 1,054 shares in the last quarter. Arizona State Retirement System grew its stake in shares of Hims & Hers Health by 3.0% in the 2nd quarter. Arizona State Retirement System now owns 40,344 shares of the company’s stock worth $815,000 after buying an additional 1,173 shares in the last quarter. Victory Capital Management Inc. increased its holdings in shares of Hims & Hers Health by 6.6% in the 2nd quarter. Victory Capital Management Inc. now owns 19,469 shares of the company’s stock worth $393,000 after buying an additional 1,212 shares during the last quarter. Finally, Rockefeller Capital Management L.P. lifted its holdings in shares of Hims & Hers Health by 5.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 33,775 shares of the company’s stock valued at $622,000 after acquiring an additional 1,864 shares during the last quarter. 63.52% of the stock is currently owned by hedge funds and other institutional investors.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.